Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Arch Biochem Biophys ; 478(1): 85-95, 2008 Oct 01.
Artigo em Inglês | MEDLINE | ID: mdl-18655767

RESUMO

Sp1 is a ubiquitous transcription factor and master regulator of various eukaryotic gene expression. Better understanding of the role of increased Sp1 levels on angiogenic regulation and the regulatory regions of that transcription factor may act as a useful target in 'transcriptional therapy'. At the molecular level, butyrate inhibits Sp1-DNA binding activity by promoting Sp1 protein dephosphorylation in EAT cells. It also inhibits Sp1 binding activity and reduces expression of VEGF gene, thereby inhibiting angiogenesis. It was confirmed that butyrate induces expression of a tyrosine phosphatase by RT-PCR, cDNA sequence analysis, protein ESI-MS analysis and protein sequence homology comparison. Thus our result strongly suggests that inhibition of angiogenesis by butyrate involves Sp1 dephosphorylation and down-regulation of VEGF gene expression. Further, butyrate inhibits neoangiogenesis induced by tumor cells and VEGF in peritoneum of EAT bearing mice and rat cornea.


Assuntos
Butiratos/farmacologia , Neovascularização Patológica , Monoéster Fosfórico Hidrolases/metabolismo , Fator de Transcrição Sp1/metabolismo , Fator A de Crescimento do Endotélio Vascular/metabolismo , Animais , Linhagem Celular Tumoral , Proliferação de Células , Córnea/metabolismo , DNA Complementar/metabolismo , Humanos , Camundongos , Ratos , Espectrometria de Massas por Ionização por Electrospray , Transcrição Gênica , Fator A de Crescimento do Endotélio Vascular/química
2.
Eur J Pharmacol ; 588(2-3): 141-50, 2008 Jul 07.
Artigo em Inglês | MEDLINE | ID: mdl-18513715

RESUMO

Octacosanol is a long-chain aliphatic alcohol, which is the main component of policosanol used as a normolipidemic agent. It is known that angiogenesis is involved in tumor growth and metastasis. The present study identified octacosanol isolated from the plant Tinospora cordifolia as a new antiangiogenic compound with inhibitory effects on in vivo angiogenesis assays. Our results showed that octacosanol (i) inhibits proliferation of endothelial cells and Ehrlich ascites tumor cells, (ii) inhibits neovascularization induced by angiogenic factors in chick chorioallantoic membrane and rat cornea in vivo angiogenesis assays, (iii) inhibits secretion of ascites fluid in the growing tumor cells in vivo. Concerning the mechanism of action, octacosanol inhibited secretion of vascular endothelial growth factor into ascites fluid by the tumor cells. At the molecular level octacosanol markedly inhibits activity of matrix metalloproteinases (MMPs) and translocation of transcription factor nuclear factor-B to nucleus. The mechanism of inhibition of angiogenesis by octacosanol reflects on its effect on tumor angiogenesis and metastasis.


Assuntos
Inibidores da Angiogênese/farmacologia , Núcleo Celular/metabolismo , DNA/metabolismo , Álcoois Graxos/farmacologia , NF-kappa B/antagonistas & inibidores , Tinospora/química , Fator A de Crescimento do Endotélio Vascular/antagonistas & inibidores , Transporte Ativo do Núcleo Celular/efeitos dos fármacos , Animais , Carcinoma de Ehrlich/tratamento farmacológico , Proliferação de Células/efeitos dos fármacos , Células Cultivadas , Galinhas , Regulação para Baixo , Humanos , Inibidores de Metaloproteinases de Matriz , Camundongos , NF-kappa B/metabolismo , Ratos , Fator A de Crescimento do Endotélio Vascular/genética
3.
Int Immunopharmacol ; 6(3): 494-8, 2006 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-16428085

RESUMO

Blood vessel plays a crucial role in solid tumor development. It has been suggested that blocking of angiogenesis and the action of the cytokine VEGF could be possible in cancer therapy. In a screen for naturally occurring angiogenic inhibitors, we have identified an extract from the roots of Glycyrrhiza glabra, which has potent antiangiogenic and antitumor activity. The aqueous extract inhibits the in vivo and in vitro proliferation of Ehrlich ascites tumor cells. The angioinhibitory activity of G. glabra was confirmed by its inhibition of angiogenesis in in vivo assays, peritoneal and chorioallantoic membrane assay. Reduction in the levels of the cytokine VEGF and microvessel density count in the peritoneum of mice treated with G. glabra indicated that the plant extract decreased VEGF production and the cytokine induced neovascularization. Our results suggest that the extract from the roots of G. glabra may be a potential supplemental source for cancer therapy.


Assuntos
Carcinoma de Ehrlich/irrigação sanguínea , Carcinoma de Ehrlich/tratamento farmacológico , Proliferação de Células/efeitos dos fármacos , Glycyrrhiza , Neovascularização Patológica/tratamento farmacológico , Extratos Vegetais/farmacologia , Fator A de Crescimento do Endotélio Vascular/antagonistas & inibidores , Fator A de Crescimento do Endotélio Vascular/fisiologia , Animais , Carcinoma de Ehrlich/metabolismo , Embrião de Galinha , Glycyrrhiza/química , Cinética , Camundongos , Neovascularização Patológica/metabolismo , Raízes de Plantas/química , Solventes , Células Tumorais Cultivadas
4.
Am J Clin Nutr ; 50(4): 731-6, 1989 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-2508459

RESUMO

While collating basal metabolic rate (BMR) measurements made worldwide it becomes important to know how different instruments compare with each other and whether errors in methodology could account for the differences in BMRs measured. BMRs of 34 healthy individuals were measured by using five different instruments in various combinations. Results show that energy outputs were comparable between the oxylog. Hartmann and Braun Metabolator, ventilated tent and hood, and whole-body indirect calorimeter: small differences, if any, were not statistically significant. However, significant interactions existed between subjects with the ventilated tent and hood and calorimeter when measurements were taken in subjects who were unaccustomed to the apparatus. When converting O2-consumption measurements to energy output, some instruments make assumptions that introduce a variable error in the final result, which may lead to systematic errors during the compilation of large databases of human BMRs.


Assuntos
Calorimetria Indireta/instrumentação , Taxa de Depuração Metabólica , Adulto , Análise de Variância , Calorimetria , Calorimetria Indireta/métodos , Dióxido de Carbono/análise , Metabolismo Energético , Humanos , Masculino , Matemática , Oxigênio/análise , Consumo de Oxigênio
5.
Br J Nutr ; 61(2): 201-8, 1989 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-2706225

RESUMO

1. Seventeen male subjects with an energy intake of 10.6 (SD 1.7) MJ/d and ten male undernourished labourers with an energy intake of 8.0 (SD 1.2) MJ/d were studied. The controls were subdivided into ten underweight controls with a body mass index (weight/height2; BMI) less than 18 (17.2 (SD 0.9)) and seven normal-weight controls with a BMI greater than 20 (21.3 (SD 1.6)), while the undernourished labourers had a BMI less than 18 (16.8 (SD 1.2)). 2. Comparison of thermogenic responses to increasing doses of noradrenaline showed no overall significant inter-group differences when subjected to a nested analysis of variance (ANOVA). For the initial doses of 0.05 and 0.1 micrograms noradrenaline, significantly lower responses were seen in the undernourished subjects, while the highest dose showed comparable responses in all three groups. Thermogenic responses to the initial two doses, when corrected for fat-free mass (FFM) differences, were 40% lower in the undernourished group when compared with the underweight group with similar BMI and FFM values. However, this finding was not statistically significant. 3. The basal oxygen consumption of the undernourished group, expressed per unit FFM, was significantly higher than that of the controls.


Assuntos
Ingestão de Energia , Norepinefrina/farmacologia , Consumo de Oxigênio/efeitos dos fármacos , Adulto , Relação Dose-Resposta a Droga , Metabolismo Energético/efeitos dos fármacos , Humanos , Masculino , Norepinefrina/administração & dosagem
6.
Metabolism ; 37(10): 907-9, 1988 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-3173109

RESUMO

A method for predicting maximal oxygen consumption during norepinephrine infusion is described. Using the initial response and enzyme kinetics, predicted values of maximal oxygen consumption were compared with observed values and a coefficient of variation of 1.4% was obtained. This method is of use in situations where it may not be possible to achieve steady-state conditions, especially with high doses of norepinephrine, and it permits comparison of maximal oxygen consumption between groups.


Assuntos
Norepinefrina/farmacologia , Consumo de Oxigênio/efeitos dos fármacos , Adulto , Regulação da Temperatura Corporal/efeitos dos fármacos , Relação Dose-Resposta a Droga , Humanos , Infusões Intravenosas , Masculino , Modelos Biológicos , Norepinefrina/administração & dosagem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...